SCHEMBL3661749

SCHEMBL3661749

CCCCc1cc(=O)c2ccc(OC)cc2o1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.68
CYP11B1 P15538 2/20 0.60
MAOB P27338 3/20 0.56
CYP11B2 P19099 1/20 0.55
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 5/20 0.53
EPHX2 P34913 1/20 0.53
TNKS O95271 1/20 0.53
CYP19A1 P11511 1/20 0.53
HPGD P15428 3/20 0.52
CYP3A4 P08684 2/20 0.52
HSD17B10 Q99714 2/20 0.52
USP2 O75604 1/20 0.52
MAPK1 P28482 1/20 0.52
RECQL P46063 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
STS P08842 1/20 0.52
MAPT P10636 2/20 0.51
MEN1 O00255 1/20 0.51
TP53 P04637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3662398 0.96 PPARG (0.67) PPARGCYP11B1MAOBCYP11B2KDM4E
SCHEMBL3658659 0.95 PPARG (0.65) PPARGCYP11B1MAOBCYP11B2KDM4E
SCHEMBL3660458 0.95 PPARG (0.65) PPARGCYP11B1MAOBCYP11B2KDM4E
SCHEMBL3659531 0.95 PPARG (0.65) PPARGCYP11B1MAOBCYP11B2KDM4E
SCHEMBL18397790 0.81 PPARG (0.65) PPARGCYP11B1MAOBCYP11B2KDM4E
SCHEMBL18397897 0.81 PPARG (0.65) PPARGCYP11B1MAOBCYP11B2KDM4E
SCHEMBL11510798 0.81 PPARG (0.65) PPARGCYP11B1MAOBCYP11B2KDM4E
SCHEMBL12325511 0.81 PPARG (0.65) PPARGCYP11B1MAOBCYP11B2KDM4E
Hydrochloric Acid SCHEMBL18397798 0.80 LOXL2 (0.64) PPARGCYP11B1MAOBCYP11B2KDM4E
SCHEMBL3661429 0.80 ALOX15 (0.72) PPARGMAOBKDM4EALDH1A1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11642288-B2 Skin external composition KAO CORPORATION (JP) 2023-05-09 US disclosed
CN-111491604-B Method for producing composition containing hardly water-soluble aromatic compound 花王株式会社 2023-03-21 CN disclosed
EP-4104862-A1 SKIN COMPOSITION FOR EXTERNAL USE Kao Corporation (JP) 2022-12-21 EP disclosed
EP-3733155-B1 METHOD FOR MANUFACTURING COMPOSITION THAT INCLUDES POORLY WATER-SOLUBLE AROMATIC COMPOUND KAO CORP (JP) 2022-11-23 EP disclosed
US-20220287923-A1 SKIN EXTERNAL COMPOSITION KAO CORPORATION (JP) 2022-09-15 US disclosed
US-11419797-B2 Method for producing composition containing hardly water-soluble aromatic compound KAO CORPORATION (JP) 2022-08-23 US disclosed
EP-4032524-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING HARDLY WATER-SOLUBLE AROMATIC COMPOUND Kao Corporation (JP) 2022-07-27 EP disclosed
CN-113950336-A Composition for external application to skin 花王株式会社 2022-01-18 CN disclosed
US-20210059909-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING HARDLY WATER-SOLUBLE AROMATIC COMPOUND KAO CORPORATION (JP) 2021-03-04 US disclosed
EP-3733155-A1 METHOD FOR MANUFACTURING COMPOSITION THAT INCLUDES POORLY WATER-SOLUBLE AROMATIC COMPOUND Kao Corporation (JP) 2020-11-04 EP disclosed
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 WO disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC PPARG 1178/4885CYP11B1 4654/4885MAOB 3870/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR PPARG 1824/4885CYP11B1 4279/4885MAOB 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.